Plasma Chemokines in Patients with Alcohol Use Disorders
Recent studies have linked changes in peripheral chemokine concentrations to the presence of both addictive behaviors and psychiatric disorders. The present study further explore this link by analyzing the potential association of psychiatry comorbidity with alterations in the concentrations of circ...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:253810 |
| Acceso en línea: | https://ddd.uab.cat/record/253810 https://dx.doi.org/urn:doi:10.3389/fpsyt.2016.00214 |
| Access Level: | acceso abierto |
| Palabra clave: | Chemokine Alcohol use disorder Psychiatric comorbidity Outpatient setting PRISM Eotaxin Sex |
| id |
ES_6343a5750d5ce1a2b0191aba4aedede2 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:253810 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Plasma Chemokines in Patients with Alcohol Use Disorders Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity |
| title |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| spellingShingle |
Plasma Chemokines in Patients with Alcohol Use Disorders García Marchena, Nuria|||0000-0002-0575-3613 Chemokine Alcohol use disorder Psychiatric comorbidity Outpatient setting PRISM Eotaxin Sex |
| title_short |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| title_full |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| title_fullStr |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| title_full_unstemmed |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| title_sort |
Plasma Chemokines in Patients with Alcohol Use Disorders |
| dc.creator.none.fl_str_mv |
García Marchena, Nuria|||0000-0002-0575-3613 Araos, Pedro|||0000-0001-5172-8796 Barrios, Vicente Sánchez-Marín, Laura Chowen, Julie A.|||0000-0002-4770-2291 Pedraz, María Castilla-Ortega, Estela Romero-Sanchiz, Pablo Ponce, Guillermo Gavito, Ana L. Decara, Juan Silva, Daniel Torrens, Marta Argente, Jesús|||0000-0001-5826-0276 Rubio, Gabriel Serrano, Antonia de Fonseca, Fernando Rodríguez Pavón, Francisco Javier |
| author |
García Marchena, Nuria|||0000-0002-0575-3613 |
| author_facet |
García Marchena, Nuria|||0000-0002-0575-3613 Araos, Pedro|||0000-0001-5172-8796 Barrios, Vicente Sánchez-Marín, Laura Chowen, Julie A.|||0000-0002-4770-2291 Pedraz, María Castilla-Ortega, Estela Romero-Sanchiz, Pablo Ponce, Guillermo Gavito, Ana L. Decara, Juan Silva, Daniel Torrens, Marta Argente, Jesús|||0000-0001-5826-0276 Rubio, Gabriel Serrano, Antonia de Fonseca, Fernando Rodríguez Pavón, Francisco Javier |
| author_role |
author |
| author2 |
Araos, Pedro|||0000-0001-5172-8796 Barrios, Vicente Sánchez-Marín, Laura Chowen, Julie A.|||0000-0002-4770-2291 Pedraz, María Castilla-Ortega, Estela Romero-Sanchiz, Pablo Ponce, Guillermo Gavito, Ana L. Decara, Juan Silva, Daniel Torrens, Marta Argente, Jesús|||0000-0001-5826-0276 Rubio, Gabriel Serrano, Antonia de Fonseca, Fernando Rodríguez Pavón, Francisco Javier |
| author2_role |
author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Chemokine Alcohol use disorder Psychiatric comorbidity Outpatient setting PRISM Eotaxin Sex |
| topic |
Chemokine Alcohol use disorder Psychiatric comorbidity Outpatient setting PRISM Eotaxin Sex |
| description |
Recent studies have linked changes in peripheral chemokine concentrations to the presence of both addictive behaviors and psychiatric disorders. The present study further explore this link by analyzing the potential association of psychiatry comorbidity with alterations in the concentrations of circulating plasma chemokine in patients of both sexes diagnosed with alcohol use disorders (AUD). To this end, 85 abstinent subjects with AUD from an outpatient setting and 55 healthy subjects were evaluated for substance and mental disorders. Plasma samples were obtained to quantify chemokine concentrations [C-C motif (CC), C-X-C motif (CXC), and C-X-C motif (CXC) chemokines]. Abstinent AUD patients displayed a high prevalence of comorbid mental disorders (72%) and other substance use disorders (45%). Plasma concentrations of chemokines CXCL12/stromal cell-derived factor-1 (p < 0.001) and CXCL1/fractalkine (p < 0.05) were lower in AUD patients compared to controls, whereas CCL11/eotaxin-1 concentrations were strongly decreased in female AUD patients (p < 0.001). In the alcohol group, CXCL8 concentrations were increased in patients with liver and pancreas diseases and there was a significant correlation to aspartate transaminase (r = +0.456, p < 0.001) and gamma-glutamyltransferase (r = +0.647, p < 0.001). Focusing on comorbid psychiatric disorders, we distinguish between patients with additional mental disorders (N = 61) and other substance use disorders (N = 38). Only CCL11 concentrations were found to be altered in AUD patients diagnosed with mental disorders (p < 0.01) with a strong main effect of sex. Thus, patients with mood disorders (N = 42) and/or anxiety (N = 16) had lower CCL11 concentrations than non-comorbid patients being more evident in women. The alcohol-induced alterations in circulating chemokines were also explored in preclinical models of alcohol use with male Wistar rats. Rats exposed to repeated ethanol (3 g/kg, gavage) had lower CXCL12 (p < 0.01) concentrations and higher CCL11 concentrations (p < 0.001) relative to vehicle-treated rats. Additionally, the increased CCL11 concentrations in rats exposed to ethanol were enhanced by the prior exposure to restraint stress (p < 0.01). Concordantly, acute ethanol exposure induced changes in CXCL12, CXCL1, and CCL11 in the same direction to repeated exposure. These results clearly indicate a contribution of specific chemokines to the phenotype of AUD and a strong effect of sex, revealing a link of CCL11 to alcohol and anxiety/stress. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2 2017-01-01 2017 2017-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/253810 https://dx.doi.org/urn:doi:10.3389/fpsyt.2016.00214 |
| url |
https://ddd.uab.cat/record/253810 https://dx.doi.org/urn:doi:10.3389/fpsyt.2016.00214 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI13/02261 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI16/01953 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CP14/00173 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CP14/00212 Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CD12/00455 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869409559362142208 |
| spelling |
Plasma Chemokines in Patients with Alcohol Use DisordersAssociation of CCL11 (Eotaxin-1) with Psychiatric ComorbidityGarcía Marchena, Nuria|||0000-0002-0575-3613Araos, Pedro|||0000-0001-5172-8796Barrios, VicenteSánchez-Marín, LauraChowen, Julie A.|||0000-0002-4770-2291Pedraz, MaríaCastilla-Ortega, EstelaRomero-Sanchiz, PabloPonce, GuillermoGavito, Ana L.Decara, JuanSilva, DanielTorrens, MartaArgente, Jesús|||0000-0001-5826-0276Rubio, GabrielSerrano, Antoniade Fonseca, Fernando RodríguezPavón, Francisco JavierChemokineAlcohol use disorderPsychiatric comorbidityOutpatient settingPRISMEotaxinSexRecent studies have linked changes in peripheral chemokine concentrations to the presence of both addictive behaviors and psychiatric disorders. The present study further explore this link by analyzing the potential association of psychiatry comorbidity with alterations in the concentrations of circulating plasma chemokine in patients of both sexes diagnosed with alcohol use disorders (AUD). To this end, 85 abstinent subjects with AUD from an outpatient setting and 55 healthy subjects were evaluated for substance and mental disorders. Plasma samples were obtained to quantify chemokine concentrations [C-C motif (CC), C-X-C motif (CXC), and C-X-C motif (CXC) chemokines]. Abstinent AUD patients displayed a high prevalence of comorbid mental disorders (72%) and other substance use disorders (45%). Plasma concentrations of chemokines CXCL12/stromal cell-derived factor-1 (p < 0.001) and CXCL1/fractalkine (p < 0.05) were lower in AUD patients compared to controls, whereas CCL11/eotaxin-1 concentrations were strongly decreased in female AUD patients (p < 0.001). In the alcohol group, CXCL8 concentrations were increased in patients with liver and pancreas diseases and there was a significant correlation to aspartate transaminase (r = +0.456, p < 0.001) and gamma-glutamyltransferase (r = +0.647, p < 0.001). Focusing on comorbid psychiatric disorders, we distinguish between patients with additional mental disorders (N = 61) and other substance use disorders (N = 38). Only CCL11 concentrations were found to be altered in AUD patients diagnosed with mental disorders (p < 0.01) with a strong main effect of sex. Thus, patients with mood disorders (N = 42) and/or anxiety (N = 16) had lower CCL11 concentrations than non-comorbid patients being more evident in women. The alcohol-induced alterations in circulating chemokines were also explored in preclinical models of alcohol use with male Wistar rats. Rats exposed to repeated ethanol (3 g/kg, gavage) had lower CXCL12 (p < 0.01) concentrations and higher CCL11 concentrations (p < 0.001) relative to vehicle-treated rats. Additionally, the increased CCL11 concentrations in rats exposed to ethanol were enhanced by the prior exposure to restraint stress (p < 0.01). Concordantly, acute ethanol exposure induced changes in CXCL12, CXCL1, and CCL11 in the same direction to repeated exposure. These results clearly indicate a contribution of specific chemokines to the phenotype of AUD and a strong effect of sex, revealing a link of CCL11 to alcohol and anxiety/stress. 22017-01-0120172017-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/253810https://dx.doi.org/urn:doi:10.3389/fpsyt.2016.00214reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI13/02261Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 PI16/01953Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CP14/00173Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CP14/00212Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CD12/00455open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2538102026-06-06T12:50:31Z |
| score |
15,301603 |